Overwhelming demand for transformative GLP-1 agonists like Ozempic and Mounjaro has led to widespread compounding and a boom in counterfeiting.

Is it safe or cost-effective to import medicine from Canada's or other countries' drug supplies?

 

Pharmacy to pharmacy marketplaces for medicine have been used to traffick counterfeits. PSM is urging better safety measures

State Prescription Drug Affordability Boards intend to control medicine costs — but some of their strategies will have unintended consequences.

After two decades of tracking counterfeit drugs, PSM is an expert on medicine safety issues and we often offer journalists our insight and perspective. 

July 28, 2025: Suspicious shipments of API continue to be sent to buyers in the U.S.

July 28, 2025

The newest Fishy Freight report continued to find suspect API shipped into the U.S. while a report from the United Nations’ Office of Drug Crime highlighted the dangers of contaminated and counterfeit medicines made with diethylene glycol and ethylene glycol.

Prescription Drug Freight Fraud Report, June 2025

July 25, 2025

What if your tirzepatide shipment came from a Brazilian beauty clinic? Or a vial of semaglutide was manufactured, supposedly, at a Costco in Toronto? In April and May 2025, dozens of shipments of semaglutide, tirzepatide, apixaban, and antibiotics entered the U.S. from facilities that aren’t in the FDA’s drug manufacturing database. These aren’t low-volume personal-use…

Final publication of guidelines for online pharmacy-to-pharmacy medicine marketplaces.

July 24, 2025

We’ve published the final document of best practices for online pharmacy-to-pharmacy marketplaces.

Partnership for Safe Medicines Applauds Reintroduction of the Cooper Davis Devin Norring Act

July 22, 2025

The Partnership for Safe Medicines (PSM) today announced its strong support for the reintroduction of the Cooper Davis Devin Norring Act, a bipartisan effort aimed at curbing the online sale of deadly counterfeit and illicit drugs.

July 21, 2025: Inspection policy for all FDA-regulated products changed at ports of entry

July 21, 2025

A policy change announced by U.S. Customs and Border Protection means that all FDA-regulated products are now subject to inspection at ports of entry.

What is a 503B outsourcing facility, and why are so many of them uninspected by FDA?

July 16, 2025

503B outsourcing facilities make our drug supply more resilient, but 81% of 503Bs newly registered since June 2021 have never been inspected by FDA staff. Learn why we recommend changes to this important program.

Pill press update: January through June 2025

July 16, 2025

Pill presses and molds are used to make fake pills with deadly consequences thousands of people every year. The number of Americans that take fake pills annually without a fatal event is even higher. Read our January through June 2025 report covering pill press seizures, policy developments, and legislation.

Like your information on video? Subscribe to our YouTube playlist!

youtube-video-thumbnail

Who's investigating a company selling research-grade weight loss injections?  Find out..

Updates on two federal prosecutions.

youtube-video-thumbnail

Click the images below to see more recent videos.